Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma
Clinical trial NCT01239797 · COMPLETED
Trial details
- NCT number
- NCT01239797
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-20
- Primary completion
- 2014-09-02
- Enrollment
- 646
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.